BUY Export Mounjaro Tirzepatide 5 mg

$230.00$360.00

🌍 Mounjaro Tirzepatide 5 mg Injection (Export) – Global-Grade Solution for Type 2 Diabetes & Weight Loss

Mounjaro Tirzepatide 5 mg is a revolutionary dual-action injectable medication developed by Eli Lilly, intended for the management of Type 2 diabetes mellitus and clinically supported for its remarkable weight loss benefits. This export-grade version is manufactured under stringent international pharmaceutical standards, making it suitable for regulated global distribution and international patient use.

Tirzepatide is the first and only dual GIP and GLP-1 receptor agonist, offering superior control of blood glucose and significantly improving metabolic outcomes. For patients struggling with blood sugar control and obesity, Mounjaro 5 mg offers an advanced, once-weekly treatment that supports both glycemic management and sustained fat reduction.

🔬 Key Benefits of Mounjaro 5 mg Export Version

  • Lowers A1C and fasting glucose in adults with Type 2 diabetes

  • ✅ Clinically proven to support healthy weight loss

  • Weekly dosing improves adherence and lifestyle convenience

  • ✅ Export-standard product for international medical use

  • ✅ Enhances insulin sensitivity and appetite regulation

  • ✅ Non-insulin therapy with dual hormone targeting

💡 How to Use

Administer Mounjaro 5 mg via subcutaneous injection (abdomen, thigh, or upper arm) once per week, on the same day each week. This 5 mg dose is typically prescribed following initiation with 2.5 mg and may be increased gradually to optimize therapeutic outcomes under a doctor’s guidance.

⚠️ Safety & Export Details

  • Exported under GDP-compliant cold chain logistics

  • Do not use in Type 1 diabetes, or during pregnancy/breastfeeding without guidance

  • Side effects may include nausea, loss of appetite, diarrhea, and fatigue

  • Consult with a healthcare provider if you have a history of thyroid cancer or pancreatitis

  • Keep refrigerated between 2°C and 8°C; do not freeze

Product Specification

Strength 7.5 mg
Packaging Size 1 ml
Packaging Type Injection
Brand Mounjaro Tirzepatide
Brand Mounjaro Tirzepatide
Manufacturer Eli Lilly and Company
Manufacturer Eli Lilly and Company
Storage Conditions refrigerator
Minimum Order Quantity 5 Vial
Item Code 4466345
Delivery Time 5 Days
Production Capacity 1000
Packaging Details Sealed in Box

Description

🌍 Mounjaro Tirzepatide 5 mg Injection (Export) – Global-Grade Solution for Type 2 Diabetes & Weight Loss

Mounjaro Tirzepatide 5 mg is a revolutionary dual-action injectable medication developed by Eli Lilly, intended for the management of Type 2 diabetes mellitus and clinically supported for its remarkable weight loss benefits. This export-grade version is manufactured under stringent international pharmaceutical standards, making it suitable for regulated global distribution and international patient use.

Tirzepatide is the first and only dual GIP and GLP-1 receptor agonist, offering superior control of blood glucose and significantly improving metabolic outcomes. For patients struggling with blood sugar control and obesity, Export Mounjaro Tirzepatide 5 mg offers an advanced, once-weekly treatment that supports both glycemic management and sustained fat reduction.

🔬 Key Benefits of Mounjaro 5 mg Export Version

  • Lowers A1C and fasting glucose in adults with Type 2 diabetes

  • ✅ Clinically proven to support healthy weight loss

  • Weekly dosing improves adherence and lifestyle convenience

  • ✅ Export-standard product for international medical use

  • ✅ Enhances insulin sensitivity and appetite regulation

  • ✅ Non-insulin therapy with dual hormone targeting

💡 How to Use

Administer Mounjaro 5 mg via subcutaneous injection (abdomen, thigh, or upper arm) once per week, on the same day each week. This 5 mg dose is typically prescribed following initiation with 2.5 mg and may be increased gradually to optimize therapeutic outcomes under a doctor’s guidance.

⚠️ Safety & Export Details

  • Exported under GDP-compliant cold chain logistics

  • Do not use in Type 1 diabetes, or during pregnancy/breastfeeding without guidance

  • Side effects may include nausea, loss of appetite, diarrhea, and fatigue

  • Consult with a healthcare provider if you have a history of thyroid cancer or pancreatitis

  • Keep refrigerated between 2°C and 8°C; do not freeze

Product Specification

Strength 7.5 mg
Packaging Size 1 ml
Packaging Type Injection
Brand Mounjaro Tirzepatide
Brand Mounjaro Tirzepatide
Manufacturer Eli Lilly and Company
Manufacturer Eli Lilly and Company
Storage Conditions refrigerator
Minimum Order Quantity 5 Vial

Additional information

PACK

A pack with 4 pens of 2.5mg/0.5, A pack with 4 pens of 5mg/0.5, A pack with 4 pens of 7.5mg/0.5ml, A pack with 4 pens of 10mg/0.5ml, A pack with 4 pens of 12.5mg, A pack with 4 pens of 15mg

Reviews

There are no reviews yet.

Be the first to review “BUY Export Mounjaro Tirzepatide 5 mg”

Your email address will not be published. Required fields are marked *